K Miwa1, S Okazaki1, M Sakaguchi1, H Mochizuki1, K Kitagawa2. 1. Department of Neurology and Stroke Center, Osaka University Graduate School of Medicine, Osaka, Japan. 2. Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan.
Abstract
BACKGROUND AND PURPOSE: Mixed neurogenerative and vascular dementia has emerged as the leading cause of dementia in the elderly. Inflammation is implicated in atherosclerosis, cerebral small-vessel disease (SVD) as well as cognitive impairment. However, longitudinal data on the predictive value of circulating inflammatory markers including gene variants and magnetic resonance imaging (MRI) findings in incident dementia are scarce. It was investigated whether circulating interleukin-6 (IL-6), C-reactive protein (CRP) and gene variants increase dementia risk. METHODS: In a cohort of Japanese participants with vascular risk factors in an observational study from 2001, the association between baseline IL-6, CRP levels, gene variants [interleukin-6 receptor (IL-6R), rs2228145; IL-6, rs2097677; CRP, rs3093059] and incident all-cause dementia was evaluated. Baseline MRI was used to determine SVD (lacuna, white matter hyperintensities) and atrophy (medial-temporal lobe atrophy, bicaudate ratio). Cox proportional hazards analyses were performed for predictors of dementia, adjusting for age, sex, apolipoprotein Eε4, education, cerebrovascular events, vascular risk factors and MRI findings. RESULTS: Of 803 subjects (mean 67.0 ± 8.5 years, males 59%), during a mean of 7.5 ± 3.2 years follow-up, 60 incident dementia patients (Alzheimer's disease 31; vascular dementia 17; mixed-type six; other six) were diagnosed. In multivariable analyses adjusted for age, sex, cerebrovascular events, MRI findings and IL-6R variant (rs2228145), IL-6 levels (relative risk 1.68, P = 0.048) or highest tertile (relative risk 2.38, P = 0.031) for all-cause dementia remained significant. Although subjects with rs2228145 carrier had significantly higher IL-6 levels, a significant association between rs2228145 and dementia was not observed. Conversely, CRP and remaining gene variants were not associated with dementia. CONCLUSIONS: The deleterious effect of higher IL-6 on dementia remains consistent irrespective of conventional risk factors, MRI findings and IL-6R variant.
BACKGROUND AND PURPOSE: Mixed neurogenerative and vascular dementia has emerged as the leading cause of dementia in the elderly. Inflammation is implicated in atherosclerosis, cerebral small-vessel disease (SVD) as well as cognitive impairment. However, longitudinal data on the predictive value of circulating inflammatory markers including gene variants and magnetic resonance imaging (MRI) findings in incident dementia are scarce. It was investigated whether circulating interleukin-6 (IL-6), C-reactive protein (CRP) and gene variants increase dementia risk. METHODS: In a cohort of Japanese participants with vascular risk factors in an observational study from 2001, the association between baseline IL-6, CRP levels, gene variants [interleukin-6 receptor (IL-6R), rs2228145; IL-6, rs2097677; CRP, rs3093059] and incident all-cause dementia was evaluated. Baseline MRI was used to determine SVD (lacuna, white matter hyperintensities) and atrophy (medial-temporal lobe atrophy, bicaudate ratio). Cox proportional hazards analyses were performed for predictors of dementia, adjusting for age, sex, apolipoprotein Eε4, education, cerebrovascular events, vascular risk factors and MRI findings. RESULTS: Of 803 subjects (mean 67.0 ± 8.5 years, males 59%), during a mean of 7.5 ± 3.2 years follow-up, 60 incident dementiapatients (Alzheimer's disease 31; vascular dementia 17; mixed-type six; other six) were diagnosed. In multivariable analyses adjusted for age, sex, cerebrovascular events, MRI findings and IL-6R variant (rs2228145), IL-6 levels (relative risk 1.68, P = 0.048) or highest tertile (relative risk 2.38, P = 0.031) for all-cause dementia remained significant. Although subjects with rs2228145 carrier had significantly higher IL-6 levels, a significant association between rs2228145 and dementia was not observed. Conversely, CRP and remaining gene variants were not associated with dementia. CONCLUSIONS: The deleterious effect of higher IL-6 on dementia remains consistent irrespective of conventional risk factors, MRI findings and IL-6R variant.
Authors: Bernhard M Kaess; Sarah R Preis; Alexa Beiser; Douglas B Sawyer; Tai C Chen; Sudha Seshadri; Ramachandran S Vasan Journal: Heart Date: 2016-06-27 Impact factor: 5.994
Authors: June E Eichner; S Terence Dunn; Ghazala Perveen; David M Thompson; Kenneth E Stewart; Berrit C Stroehla Journal: Am J Epidemiol Date: 2002-03-15 Impact factor: 4.897
Authors: Swapnil N Rajpathak; Tao Wang; Sylvia Wassertheil-Smoller; Howard D Strickler; Robert C Kaplan; Aileen P McGinn; Rachel P Wildman; Daniel Rosenbaum; Thomas E Rohan; Philipp E Scherer; Mary Cushman; Gloria Y F Ho Journal: Stroke Date: 2010-03-04 Impact factor: 7.914
Authors: Elizabeth J Bell; Nicholas B Larson; Paul A Decker; James S Pankow; Michael Y Tsai; Naomi Q Hanson; Christina L Wassel; W T Longstreth; Suzette J Bielinski Journal: Stroke Date: 2016-10-11 Impact factor: 7.914
Authors: Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan Journal: Eur Heart J Date: 2009-02-17 Impact factor: 29.983
Authors: Rosebud O Roberts; David S Knopman; Scott A Przybelski; Michelle M Mielke; Kejal Kantarci; Gregory M Preboske; Matthew L Senjem; Vernon S Pankratz; Yonas E Geda; Bradley F Boeve; Robert J Ivnik; Walter A Rocca; Ronald C Petersen; Clifford R Jack Journal: Neurology Date: 2014-03-19 Impact factor: 9.910
Authors: Kasra Moazzami; Melinda C Power; Rebecca Gottesman; Thomas Mosley; Pamela L Lutsey; Clifford R Jack; Ron C Hoogeveen; Nancy West; David S Knopman; Alvaro Alonso Journal: Neuroimage Date: 2020-09-01 Impact factor: 6.556
Authors: Angeles Vinuesa; Carlos Pomilio; Amal Gregosa; Melisa Bentivegna; Jessica Presa; Melina Bellotto; Flavia Saravia; Juan Beauquis Journal: Front Neurosci Date: 2021-04-23 Impact factor: 4.677
Authors: Irene Maeve Rea; David S Gibson; Victoria McGilligan; Susan E McNerlan; H Denis Alexander; Owen A Ross Journal: Front Immunol Date: 2018-04-09 Impact factor: 7.561
Authors: Audrey C Leasure; Lindsey R Kuohn; Kevin N Vanent; Matthew B Bevers; W Taylor Kimberly; Thorsten Steiner; Stephan A Mayer; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Stroke Date: 2021-03-08 Impact factor: 7.914